Can Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Can Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Guoming Li
Cardiovascular Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China
2 shared publicationsJinhai Quan
Affiliated Hospital of Guangdong Medical University, China
2 shared publicationsWei Lei
Laboratory of Cardiovascular Diseases, Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China
2 shared publicationsXiaorong Shui
Laboratory of Vascular Surgery, Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China
2 shared publicationsYuan He
Laboratory of Cardiovascular Diseases, Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China
2 shared publicationsGuosen Yan
Laboratory of Cardiovascular Diseases, Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China
1 shared publication
Latest Publications
- Open Access
- 31 December 2023
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (15) , 204-209
Identification of oxidative stress-related genes associated with immune cells in Aortic Valve Stenosis based on bioinformatics analysis
Aortic valve stenosis (AS) is the most common clinical valvular heart disease. Without effective pharmaceutical therapy at present, identifying effective therapeutic targets is critical. However, the pathological and molecular mechanisms of aortic stenosis are complex, including inflammatory infiltration, oxidative stress and so on. In this study, we investigated how oxidative stress interacts with immune cell infiltration in aortic stenosis using bioinformatics analysis, and provide a better understanding of aortic valve stenosis at the pathophysiologic level. After obtaining the datasets, including GSE153555, GSE51472 and GSE12644, from the Gene Expression Omnibus (GEO) database, the package ‘limma’ was applied to identify the differentially expressed genes (DEGs) in GSE153555. The GeneCards database searched for oxidative stress-related genes. We evaluated the expression of 22 immune cells using Cibersort. Clustering differentially expressed genes into different modules via Weighted gene correlation network analysis (WGCNA) and exploring the relationship among modules and immune cell types. The genes in modules intersected with oxidative stress-related genes to find oxidative stress genes related to immune infiltration. Finally, the GSE51472 and GSE12644 datasets were used to initially verify oxidative stress-related genes in aortic valve stenosis. A total of 1213 differentially expressed genes were identified in the GSE153555 dataset, and 279 of them were oxidative stress-related genes. Increased infiltration of B cell navie and Macrophages M1 in aortic stenosis was found. Using WGCNA, we clustered 15 modules. The brown module was identified as the most significant template positively correlated with T-cell regulatory Treg, and the magenta module was identified as a critical module associated with M1 macrophages with the highest negative correlation coefficient. The results verified by other datasets showed that in comparison to normal people, the aortic stenosis patients exhibited dramatically high IGFBP2 and SPHK1 expression. Both IGFBP2 and SPHK1 may be significantly involved in the mechanism of aortic stenosis pathophysiologically and can be used for aortic stenosis early detection, therapy, and therapeutic targets.
- 31 December 2023
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (15) , 204-209
Open AccessIdentification of oxidative stress-related genes associated with immune cells in Aortic Valve Stenosis based on bioinformatics analysis
Aortic valve stenosis (AS) is the most common clinical valvular heart disease. Without effective pharmaceutical therapy at present, identifying effective therapeutic targets is critical. However, the pathological and molecular mechanisms of aortic stenosis are complex, including inflammatory infiltration, oxidative stress and so on. In this study, we investigated how oxidative stress interacts with immune cell infiltration in aortic stenosis using bioinformatics analysis, and provide a better understanding of aortic valve stenosis at the pathophysiologic level. After obtaining the datasets, including GSE153555, GSE51472 and GSE12644, from the Gene Expression Omnibus (GEO) database, the package ‘limma’ was applied to identify the differentially expressed genes (DEGs) in GSE153555. The GeneCards database searched for oxidative stress-related genes. We evaluated the expression of 22 immune cells using Cibersort. Clustering differentially expressed genes into different modules via Weighted gene correlation network analysis (WGCNA) and exploring the relationship among modules and immune cell types. The genes in modules intersected with oxidative stress-related genes to find oxidative stress genes related to immune infiltration. Finally, the GSE51472 and GSE12644 datasets were used to initially verify oxidative stress-related genes in aortic valve stenosis. A total of 1213 differentially expressed genes were identified in the GSE153555 dataset, and 279 of them were oxidative stress-related genes. Increased infiltration of B cell navie and Macrophages M1 in aortic stenosis was found. Using WGCNA, we clustered 15 modules. The brown module was identified as the most significant template positively correlated with T-cell regulatory Treg, and the magenta module was identified as a critical module associated with M1 macrophages with the highest negative correlation coefficient. The results verified by other datasets showed that in comparison to normal people, the aortic stenosis patients exhibited dramatically high IGFBP2 and SPHK1 expression. Both IGFBP2 and SPHK1 may be significantly involved in the mechanism of aortic stenosis pathophysiologically and can be used for aortic stenosis early detection, therapy, and therapeutic targets.
- 20 September 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (5) , 4383-4390
Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications
- 20 September 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (5) , 4383-4390
Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications
- 5 May 2014
- Published by Wiley in Cell Biology International
- Vol. 38 (9) , 1041-1049
Subcellular distribution patterns and elevated expression of GNA11 and GNA14 proteins in the lungs of humans with pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH), a progressive and devastating disease, is characterized by abnormal proliferation of pulmonary artery endothelial and smooth muscle cells. GTP‐binding protein subunits, GNA11 and GNA14, transmembrane and intracellular signaling molecules, participate in the regulating endothelial function and vascular development. We followed the expression of GNA11 and GNA14 in human lungs in control and PAH patients using immunohistochemical and Western blot analyses. Both GNA11 and GNA14 were expressed in lung tissue, primarily in artery endothelial and smooth muscle cells. Expression was more pronounced in PAH lung tissues compared with controls. Using immunocytochemistry and laser scanning confocal microscopy, the subcellular distribution of GNA11 and GNA14 in human pulmonary arterial endothelial (HPAECs) and smooth muscle (HPASMCs) cells in culture was investigated. GNA11 was predominantly localized in the cytoplasm and nucleus of HPASMCs, but it was only found in the cytoplasm of HPAECs. On the other hand, GNA14 immunolocalized to the nucleus and cytoplasm of both HPAECs and HPASMCs. Based on bioinformatic analyses, nuclear localization signal and transmembrane topology confirm the different subcellular distributions of GNA11 and GNA14. The data suggest that GNA11 and GNA14 are related to PAH pathogenesis, and help further functional studies of these proteins in this severe disease.
- 5 May 2014
- Published by Wiley in Cell Biology International
- Vol. 38 (9) , 1041-1049
Subcellular distribution patterns and elevated expression of GNA11 and GNA14 proteins in the lungs of humans with pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH), a progressive and devastating disease, is characterized by abnormal proliferation of pulmonary artery endothelial and smooth muscle cells. GTP‐binding protein subunits, GNA11 and GNA14, transmembrane and intracellular signaling molecules, participate in the regulating endothelial function and vascular development. We followed the expression of GNA11 and GNA14 in human lungs in control and PAH patients using immunohistochemical and Western blot analyses. Both GNA11 and GNA14 were expressed in lung tissue, primarily in artery endothelial and smooth muscle cells. Expression was more pronounced in PAH lung tissues compared with controls. Using immunocytochemistry and laser scanning confocal microscopy, the subcellular distribution of GNA11 and GNA14 in human pulmonary arterial endothelial (HPAECs) and smooth muscle (HPASMCs) cells in culture was investigated. GNA11 was predominantly localized in the cytoplasm and nucleus of HPASMCs, but it was only found in the cytoplasm of HPAECs. On the other hand, GNA14 immunolocalized to the nucleus and cytoplasm of both HPAECs and HPASMCs. Based on bioinformatic analyses, nuclear localization signal and transmembrane topology confirm the different subcellular distributions of GNA11 and GNA14. The data suggest that GNA11 and GNA14 are related to PAH pathogenesis, and help further functional studies of these proteins in this severe disease.